- Filed
- Feb 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Jan 5, 2025 | 43.58M sh |
| Shares Diluted | Q3 2025 · Jan 5, 2025 | 43.13M sh |
| Shares Diluted restated | Q3 2025 · Jan 7, 2024 | 37.06M sh |
| Shares Diluted restated | Q3 2025 · Jan 7, 2024 | 13.32M sh |
| Shares Outstanding | Q3 2025 · Jan 5, 2025 | 41.04M sh |
| Shares Outstanding | Q3 2025 · Apr 28, 2024 | 40.09M sh |
| Shares Outstanding | Q3 2025 · Dec 29, 2023 | 39.92M sh |
| Shares Outstanding | Q3 2025 · Dec 28, 2023 | 17.42M sh |
| Capex | Q3 2025 · Jan 5, 2025 | $11.07M |
| Capex | Q3 2025 · Jan 7, 2024 | $14.77M |
| Operating Cash Flow | Q3 2025 · Jan 5, 2025 | −$2.49M |
| Operating Cash Flow | Q3 2025 · Jan 7, 2024 | −$15.82M |
| Long Term Debt | Q3 2025 · Jan 5, 2025 | $84.97M |
| Long Term Debt | Q3 2025 · Apr 28, 2024 | $70.68M |
| Short Term Debt | Q3 2025 · Jan 5, 2025 | $95K |
| Short Term Debt | Q3 2025 · Apr 28, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Jan 5, 2025 | $2.39M |
| Cash And Equivalents | Q3 2025 · Apr 28, 2024 | $13.17M |
| Stockholders Equity | Q3 2025 · Jan 5, 2025 | −$95.71M |
| Stockholders Equity | Q3 2025 · Oct 13, 2024 | −$88.85M |
| Stockholders Equity | Q3 2025 · Jul 21, 2024 | −$78.69M |
| Stockholders Equity | Q3 2025 · Apr 28, 2024 | −$69.16M |
| Stockholders Equity | Q3 2025 · Jan 7, 2024 | −$60.24M |
| Stockholders Equity | Q3 2025 · Oct 15, 2023 | −$128.58M |
| Stockholders Equity | Q3 2025 · Jul 23, 2023 | −$119.46M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | −$115M |
| Current Liabilities | Q3 2025 · Jan 5, 2025 | $73.5M |
| Current Liabilities | Q3 2025 · Apr 28, 2024 | $69.88M |
| Total Liabilities | Q3 2025 · Jan 5, 2025 | $258.57M |
| Total Liabilities | Q3 2025 · Apr 28, 2024 | $236.48M |
| Current Assets | Q3 2025 · Jan 5, 2025 | $8.09M |
| Current Assets | Q3 2025 · Apr 28, 2024 | $17.36M |
| Total Assets | Q3 2025 · Jan 5, 2025 | $162.86M |
| Total Assets | Q3 2025 · Apr 28, 2024 | $167.32M |
| Eps Diluted | Q3 2025 · Jan 5, 2025 | −$0.19 |
| Eps Diluted | Q3 2025 · Jan 5, 2025 | −$0.64 |
| Eps Diluted | Q3 2025 · Jan 7, 2024 | $0.33 |
| Eps Diluted | Q3 2025 · Jan 7, 2024 | −$0.03 |
| Eps Basic | Q3 2025 · Jan 5, 2025 | −$0.19 |
| Eps Basic | Q3 2025 · Jan 5, 2025 | −$0.64 |
| Eps Basic | Q3 2025 · Jan 7, 2024 | $0.35 |
| Eps Basic | Q3 2025 · Jan 7, 2024 | −$0.03 |
| Sga Expense | Q3 2025 · Jan 5, 2025 | $4.82M |
| Sga Expense | Q3 2025 · Jan 5, 2025 | $15.4M |
| Sga Expense | Q3 2025 · Jan 7, 2024 | $5.27M |
| Sga Expense | Q3 2025 · Jan 7, 2024 | $12.58M |
| Net Income | Q3 2025 · Jan 5, 2025 | −$8.08M |
| Net Income | Q3 2025 · Jan 5, 2025 | −$27.4M |
| Net Income | Q3 2025 · Oct 13, 2024 | −$9.31M |
| Net Income | Q3 2025 · Jul 21, 2024 | −$10.01M |
| Net Income | Q3 2025 · Jan 7, 2024 | $12.25M |
| Net Income | Q3 2025 · Jan 7, 2024 | $1.92M |
| Net Income | Q3 2025 · Oct 15, 2023 | −$7.28M |
| Net Income | Q3 2025 · Jul 23, 2023 | −$3.05M |
| Operating Income | Q3 2025 · Jan 5, 2025 | −$3.24M |
| Operating Income | Q3 2025 · Jan 5, 2025 | −$18.72M |
| Operating Income | Q3 2025 · Jan 7, 2024 | −$3.06M |
| Operating Income | Q3 2025 · Jan 7, 2024 | −$11.14M |
| Revenue | Q3 2025 · Jan 5, 2025 | $35.52M |
| Revenue | Q3 2025 · Jan 5, 2025 | $92.59M |
| Revenue | Q3 2025 · Jan 7, 2024 | $32.16M |
| Revenue | Q3 2025 · Jan 7, 2024 | $82.53M |